Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28588020

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Aug 10
First author
Stein EM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Aug 10;130(6):693-694. doi: 10.1182/blood-2017-06-790394.
    note
    Source null
    related pmid
    28798056
    relationship
    Comment in

Authors and identifiers

  1. name
    Stein EM
    type
    Author
  2. name
    DiNardo CD
    type
    Author
  3. name
    Pollyea DA
    type
    Author
  4. name
    Fathi AT
    type
    Author
  5. name
    Roboz GJ
    type
    Author
  6. name
    Altman JK
    type
    Author
  7. name
    Stone RM
    type
    Author
  8. name
    DeAngelo DJ
    type
    Author
  9. name
    Levine RL
    type
    Author
  10. name
    Flinn IW
    type
    Author
  11. name
    Kantarjian HM
    type
    Author
  12. name
    Collins R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Stein EM
    type
    Author
  2. name
    DiNardo CD
    type
    Author
  3. name
    Pollyea DA
    type
    Author
  4. name
    Fathi AT
    type
    Author
  5. name
    Roboz GJ
    type
    Author
  6. name
    Altman JK
    type
    Author
  7. name
    Stone RM
    type
    Author
  8. name
    DeAngelo DJ
    type
    Author
  9. name
    Levine RL
    type
    Author
  10. name
    Flinn IW
    type
    Author
  11. name
    Kantarjian HM
    type
    Author
  12. name
    Collins R
    type
    Author
bibliography ids
  1. nci-bib-1b26602f21b8f5e42cc840d0
book metadata
content sha256
6507b07ad3b7e38338b241fe8da0e6287b908d990b5674ee7dd84d8ca97c42cb
document type
citation
dois
  1. 10.1182/blood-2017-04-779405
electronic publication date
display
2017 Jun 6
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28588020
immutable id
pubmed:28588020@6507b07ad3b7e38338b241fe8da0e6287b908d990b5674ee7dd84d8ca97c42cb
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
6
name
Blood
nlm unique id
7603509
pages
722-731
volume
130
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Aug 10;130(6):693-694. doi: 10.1182/blood-2017-06-790394.
    note
    Source null
    related pmid
    28798056
    relationship
    Comment in
outcomes validated
false
pmid
28588020
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
4e9378ed4aca76cb004ef3b00dd9d182c200082ed189b88181c959eca7aca518
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug 10
precision
day
year
2017
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28588020/
title
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Preserved source evidence · Not medical advice